Lpl Financial LLC Vista Gen Therapeutics, Inc. Transaction History

Lpl Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.14 - $2.09 $36,480 - $66,880	32,000 New	32,000 $40,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $55,834 - $92,277	-33,434 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $8,997 - $11,847	3,434 Added 11.45%	33,434 $92,000
Q2 2021 Aug 13, 2021	SELL	$1.96 - $3.15 $19,600 - $31,500	-10,000 Reduced 25.0%	30,000 $95,000
Q1 2021 May 14, 2021	BUY	$1.89 - $2.96 $28,350 - $44,400	15,000 Added 60.0%	40,000 $85,000
Q4 2020 Feb 12, 2021	SELL	$0.65 - $1.94 $16,250 - $48,500	-25,000 Reduced 50.0%	25,000 $49,000
Q3 2020 Nov 09, 2020	BUY	$0.48 - $1.03 $4,800 - $10,300	10,000 Added 25.0%	50,000 $35,000
Q1 2020 May 14, 2020	BUY	$0.32 - $0.8 $4,800 - $12,000	15,000 Added 60.0%	40,000 $18,000
Q4 2019 Feb 14, 2020	SELL	$0.3 - $1.41 $11,250 - $52,875	-37,500 Reduced 60.0%	25,000 $17,000
Q3 2019 Nov 13, 2019	BUY	$0.46 - $1.29 $11,500 - $32,250	25,000 Added 66.67%	62,500 $67,000
Q2 2019 Aug 09, 2019	BUY	$0.54 - $1.33 $20,250 - $49,875	37,500 New	37,500 $27,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $517M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.